Brief: Hofseth Biocare Q2 Gross Oper Rev Up At NOK 80.4 Mln
Aug 23 (Reuters) - Hofseth Biocare ASA HBC.OL :
* GROSS OPERATING REVENUES OF NOK 80.4M (76.4M) IN Q2
* GROSS MARGIN IN Q2 WAS 34 PERCENT, WHICH IS LOWER THAN Q1
* IS STILL TARGETING C. 50 % GROWTH IN SALES, A HIGHER CAPACITY UTILIZATION AND POSITIVE
EBITDA AT
END OF YEAR
Source text for Eikon: ID:nGNE68nqXk
Further company coverage: HBC.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Hofseth Biocare ASA
See all newsBrief: Hofseth BioCare Board Member Buys 2.5 Mln Shares in Company
Brief: Hofseth Biocare Appoints Leif Arne Giske As CFO
Hofseth BioCare Q2 operating revenue slips on lower raw material volumes
Brief: Hofseth Biocare Q2 Revenue NOK 65.7 Million
Brief: Research Corporation Buys 14.3 Mln Shares In Hofseth Biocare